Classification Term: 168227

Diacylglycerophosphocholines [GP0101] (ontology term: 695b43bdaf4b6af0ee302b2d915601ee)

Diacylglycerophosphocholines [GP0101]

found 176 associated metabolites at sub_class metabolite taxonomy ontology rank level.

Ancestor: Glycerophosphocholines [GP01]

Child Taxonomies: There is no child term of current ontology term.

PC(16:0/18:1(9Z))

(2-{[(2R)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5777742)


PC(16:0/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/18:1(9Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of oleic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine is a phosphatidylcholine 34:1 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z-octadecenoyl (oleoyl) respectively. It has a role as a mouse metabolite. It is a phosphatidylcholine 34:1 and a 1-acyl-2-oleoyl-sn-glycero-3-phosphocholine betaine. It is functionally related to a hexadecanoic acid and an oleic acid. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine is a natural product found in Streptomyces roseicoloratus, Vitis vinifera, and other organisms with data available. PC(16:0/18:1(9Z)) is a metabolite found in or produced by Saccharomyces cerevisiae. PC(16:0/18:1(9z)) is a phosphatidylchloline (PC). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylcholines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PC(16:0/18:1(9z)), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. In E. coli, PCs can be found in the integral component of the cell outer membrane. They are hydrolyzed by Phospholipases to a 2-acylglycerophosphocholine and a carboxylate. A phosphatidylcholine 34:1 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z-octadecenoyl (oleoyl) respectively.

   

PC(16:0/18:2(9Z,12Z))

3,5,8-Trioxa-4-phosphahexacosa-17,20-dien-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-(((1-oxohexadecyl)oxy)methyl)-, inner salt, 4-oxide, (7R,17Z,20Z)-

C42H80NO8P (757.562125)


PC(16:0/18:2(9Z,12Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/18:2(9Z,12Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of linoleic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the linoleic acid moiety is derived from seed oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Palmitoyl-linoleoyl phosphatidylcholine, also known as phosphatidylcholine(16:0/18:2) or pc(16:0/18:2), is a member of the class of compounds known as phosphatidylcholines. Phosphatidylcholines are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage. Thus, palmitoyl-linoleoyl phosphatidylcholine is considered to be a glycerophosphocholine lipid molecule. Palmitoyl-linoleoyl phosphatidylcholine is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Palmitoyl-linoleoyl phosphatidylcholine can be found in a number of food items such as wax gourd, rowanberry, arrowroot, and chicory leaves, which makes palmitoyl-linoleoyl phosphatidylcholine a potential biomarker for the consumption of these food products. Palmitoyl-linoleoyl phosphatidylcholine can be found primarily in blood, saliva, and urine, as well as throughout all human tissues. In humans, palmitoyl-linoleoyl phosphatidylcholine is involved in a couple of metabolic pathways, which include phosphatidylcholine biosynthesis PC(16:0/18:2(9Z,12Z)) and phosphatidylethanolamine biosynthesis PE(16:0/18:2(9Z,12Z)). Moreover, palmitoyl-linoleoyl phosphatidylcholine is found to be associated with schizophrenia. 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine is a phosphatidylcholine 34:2 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z,12Z-octadecadienoyl (linoleoyl) respectively. It is a phosphatidylcholine 34:2 and a 1-acyl-2-linoleoyl-sn-glycero-3-phosphocholine betaine. A complex mixture of phospholipids, glycolipids, triglycerides, phosphatidylcholines, phosphatidylethanolamines, and phosphatidylinositols. 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine is a natural product found in Lycoris radiata, Vitis vinifera, and Drosophila melanogaster with data available. Lecithin is a phospholipid with a polar choline found in phosphoester linkage to diacylglycerol. A phosphatidylcholine 34:2 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z,12Z-octadecadienoyl (linoleoyl) respectively. Lecithin is regarded as a safe, conventional phospholipid source. Phospholipids are reported to alter the fatty acid composition and microstructure of the membranes in animal cells. Lecithin is regarded as a safe, conventional phospholipid source. Phospholipids are reported to alter the fatty acid composition and microstructure of the membranes in animal cells.

   

PC(18:0/20:1(11Z))

(2-{[(2R)-2-[(11Z)-icos-11-enoyloxy]-3-(octadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


PC(18:0/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/20:1(11Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(16:0/20:1(11Z))

(2-{[(2R)-3-(hexadecanoyloxy)-2-[(11Z)-icos-11-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C44H86NO8P (787.6090726)


PC(16:0/20:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/20:1(11Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(16:0/22:1(13Z))

(2-{[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-(hexadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


PC(16:0/22:1(13Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/22:1(13Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of erucic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(16:0/24:1(15Z))

(2-{[(2R)-3-(hexadecanoyloxy)-2-[(15Z)-tetracos-15-enoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

C48H94NO8P (843.6716693999999)


PC(16:0/24:1(15Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/24:1(15Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of nervonic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the nervonic acid moiety is derived from fish oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(18:0/16:1(9Z))

(2-{[(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-(octadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C42H82NO8P (759.5777742)


PC(18:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/16:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/16:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(18:0/22:1(13Z))

(2-{[(2R)-2-[(13Z)-docos-13-enoyloxy]-3-(octadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C48H94NO8P (843.6716693999999)


PC(18:0/22:1(13Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/22:1(13Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of erucic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the erucic acid moiety is derived from seed oils and avocados. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(18:1(9Z)/20:0)

(2-{[(2R)-2-(icosanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C46H90NO8P (815.640371)


PC(18:1(9Z)/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/20:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(18:1(9Z)/22:0)

(2-{[(2R)-2-(docosanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

C48H94NO8P (843.6716693999999)


PC(18:1(9Z)/22:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/22:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of behenic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(18:1(9Z)/24:0)

trimethyl(2-{[(2R)-3-[(9Z)-octadec-9-enoyloxy]-2-(tetracosanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C50H98NO8P (871.7029678)


PC(18:1(9Z)/24:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/24:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:1(9Z)/24:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/24:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of lignoceric acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the lignoceric acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(18:2(9Z,12Z)/16:0)

(2-{[(2R)-2-(hexadecanoyloxy)-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C42H80NO8P (757.562125)


PC(18:2(9Z,12Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:2(9Z,12Z)/16:0), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The linoleic acid moiety is derived from seed oils, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PC(24:0/18:1(9Z))

trimethyl(2-{[(2R)-2-[(9Z)-octadec-9-enoyloxy]-3-(tetracosanoyloxy)propyl phosphonato]oxy}ethyl)azanium

C50H98NO8P (871.7029678)


PC(24:0/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(24:0/18:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of oleic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(24:0/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(24:0/18:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position and one chain of oleic acid at the C-2 position. The lignoceric acid moiety is derived from groundnut oil, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC 33:0

1-nonadecanoyl-2-tetradecanoyl-sn-glycero-3-phosphocholine

C41H82NO8P (747.5777742)


Found in mouse brain; TwoDicalId=799; MgfFile=160720_brain_normal_05_Neg; MgfId=1122

   

PC 33:1

1-pentadecanoyl-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C41H80NO8P (745.562125)


Found in mouse spleen; TwoDicalId=414; MgfFile=160729_spleen_EPA_09_Neg; MgfId=983 Found in mouse muscle; TwoDicalId=254; MgfFile=160824_Muscle_AA_Neg_19; MgfId=868 Found in mouse small intestine; TwoDicalId=750; MgfFile=160907_Small_Intestine_normal_Neg_01_never; MgfId=1203

   

PC 36:3

1-(9Z,12Z-octadecadienoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C44H82NO8P (783.5777742)


Found in mouse small intestine; TwoDicalId=71; MgfFile=160907_Small_Intestine_EPA_Neg_08; MgfId=1172 Found in mouse muscle; TwoDicalId=61; MgfFile=160824_Muscle_normal_Neg_01_sute; MgfId=959

   

PC 38:4

1-(8Z,11Z,14Z-eicosatrienoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C46H84NO8P (809.5934234)


Found in mouse small intestine; TwoDicalId=451; MgfFile=160907_Small_Intestine_normal_Neg_01_2; MgfId=1200 Found in mouse small intestine; TwoDicalId=40; MgfFile=160907_Small_Intestine_AA_Neg_16_never; MgfId=1424 Found in mouse muscle; TwoDicalId=122; MgfFile=160824_Muscle_AA_Neg_20; MgfId=1086 Found in mouse lung; TwoDicalId=123; MgfFile=160901_Lung_AA_Neg_17; MgfId=1111

   

PC 40:1

1-hexadecanoyl-2-(15Z-tetracosenoyl)-sn-glycero-3-phosphocholine

C48H94NO8P (843.6716693999999)


Found in mouse spleen; TwoDicalId=411; MgfFile=160729_spleen_normal_02_Neg_never; MgfId=1797

   

PC 38:8

1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-2-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphocholine

C46H76NO8P (801.5308266)


Found in mouse muscle; TwoDicalId=442; MgfFile=160824_Muscle_DHA_Neg_12; MgfId=565

   

PC 35:1

1-heptadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine

C43H84NO8P (773.5934234)


Found in mouse lung; TwoDicalId=1070; MgfFile=160901_Lung_AA_Neg_20; MgfId=1196

   

PC 35:2

1-(9Z,12Z-octadecadienoyl)-2-heptadecanoyl-glycero-3-phosphocholine

C43H82NO8P (771.5777742)


Found in mouse small intestine; TwoDicalId=471; MgfFile=160907_Small_Intestine_DHA_Neg_14; MgfId=1290

   

PC(17:0/20:4)

1-(11Z,14Z-eicosadienoyl)-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C45H82NO8P (795.5777742)


Found in mouse small intestine; TwoDicalId=498; MgfFile=160907_Small_Intestine_AA_Neg_16; MgfId=1246

   

PC 35:3

1-(9Z,12Z,15Z-octadecatrienoyl)-2-heptadecanoyl-glycero-3-phosphocholine

C43H80NO8P (769.562125)


Found in mouse small intestine; TwoDicalId=1048; MgfFile=160907_Small_Intestine_EPA_Neg_08; MgfId=1056

   

PC 38:3

1-(11Z,14Z-eicosadienoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C46H86NO8P (811.6090726)


Found in mouse small intestine; TwoDicalId=310; MgfFile=160907_Small_Intestine_EPA_Neg_08; MgfId=1511

   

PC 40:4

1-(13Z-docosenoyl)-2-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphocholine

C48H88NO8P (837.6247218)


Found in mouse kidney; TwoDicalId=2481; MgfFile=160827_Kidney_EPA_Neg_08; MgfId=1806 Found in mouse heart; TwoDicalId=220; MgfFile=160902_Heart_AA_Neg_20; MgfId=1298

   

PC 42:2

1-(15Z-tetracosenoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C50H96NO8P (869.6873185999999)


Found in mouse brain; TwoDicalId=218; MgfFile=160720_brain_AA_19_Neg; MgfId=2267

   

PC 39:4

1-(13Z,16Z-docosadienoyl)-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C47H86NO8P (823.6090726)


Found in mouse heart; TwoDicalId=1799; MgfFile=160902_Heart_AA_Neg_18; MgfId=1085

   

PC 44:8

1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-2-(13Z,16Z-docosadienoyl)-glycero-3-phosphocholine

C52H88NO8P (885.6247218)


Found in mouse spleen; TwoDicalId=534; MgfFile=160729_spleen_AA_19_Neg; MgfId=1242

   

PC 28:0

1-pentadecanoyl-2-tridecanoyl-sn-glycero-3-phosphocholine

C36H72NO8P (677.4995282)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents Found in mouse lung; TwoDicalId=325; MgfFile=160901_Lung_AA_Neg_17; MgfId=631

   

PC 30:0

1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phosphocholine

C38H76NO8P (705.5308266)


Found in mouse lung; TwoDicalId=31; MgfFile=160901_Lung_normal_Neg_03; MgfId=709

   

PC 30:1

1-tetradecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phosphocholine

C38H74NO8P (703.5151774)


Found in mouse lung; TwoDicalId=150; MgfFile=160901_Lung_AA_Neg_17; MgfId=678 Found in mouse muscle; TwoDicalId=461; MgfFile=160824_Muscle_normal_Neg_01; MgfId=657

   

PC 32:2

1-tetradecanoyl-2-(11Z,14Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C40H76NO8P (729.5308266)


Found in mouse lung; TwoDicalId=192; MgfFile=160901_Lung_normal_Neg_03; MgfId=560 Found in mouse spleen; TwoDicalId=293; MgfFile=160729_spleen_EPA_06_Neg; MgfId=654 Found in mouse small intestine; TwoDicalId=863; MgfFile=160907_Small_Intestine_normal_Neg_01_2; MgfId=918

   

PC 32:3

1-tetradecanoyl-2-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphocholine

C40H74NO8P (727.5151774)


Found in mouse muscle; TwoDicalId=2500; MgfFile=160824_Muscle_normal_Neg_01_sute; MgfId=611

   

PC 34:4

1-(9Z,11E,13E,15Z-octadecatetraenoyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine

C42H76NO8P (753.5308266)


Found in mouse muscle; TwoDicalId=139; MgfFile=160824_Muscle_AA_Neg_18; MgfId=646

   

PC 34:5

1-(9Z-hexadecenoyl)-2-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-sn-glycero-3-phosphocholine

C42H74NO8P (751.5151774)


Found in mouse muscle; TwoDicalId=1582; MgfFile=160824_Muscle_EPA_Neg_06; MgfId=520

   

PC 36:6

1-(9E,11E,13E,15E-octadecatetraenoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C44H76NO8P (777.5308266)


Found in mouse liver; TwoDicalId=168; MgfFile=160824_Liver_EPA_Neg_09; MgfId=420 Found in mouse muscle; TwoDicalId=81; MgfFile=160824_Muscle_DHA_Neg_11; MgfId=680

   

PC 31:0

1-hexadecanoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C39H78NO8P (719.5464757999999)


Found in mouse lung; TwoDicalId=174; MgfFile=160901_Lung_AA_Neg_17_never; MgfId=981

   

PC 33:2

1-pentadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C41H78NO8P (743.5464757999999)


Found in mouse small intestine; TwoDicalId=510; MgfFile=160907_Small_Intestine_EPA_Neg_06; MgfId=1017

   

PC 35:4

1-(9Z,12E-octadecadienoyl)-2-(9Z,11E-heptadecadienoyl)-sn-glycero-3-phosphocholine

C43H78NO8P (767.5464757999999)


Found in mouse small intestine; TwoDicalId=586; MgfFile=160907_Small_Intestine_AA_Neg_18; MgfId=1026

   

PC 35:5

1-(9Z,12Z,15Z-octadecatrienoyl)-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C43H76NO8P (765.5308266)


Found in mouse small intestine; TwoDicalId=889; MgfFile=160907_Small_Intestine_EPA_Neg_06; MgfId=907

   

PC 37:6

1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C45H78NO8P (791.5464757999999)


Found in mouse heart; TwoDicalId=234; MgfFile=160902_Heart_DHA_Neg_12; MgfId=762

   

PC 32:0

1-heptadecanoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C40H80NO8P (733.562125)


Found in mouse lung; TwoDicalId=6; MgfFile=160901_Lung_AA_Neg_17_never; MgfId=1093

   

PC 32:1

1-(11Z-octadecenoyl)-2-tetradecanoyl-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)


Found in mouse lung; TwoDicalId=14; MgfFile=160901_Lung_normal_Neg_03; MgfId=735

   

PC 34:0

1-nonadecanoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C42H84NO8P (761.5934234)


Found in mouse brain; TwoDicalId=92; MgfFile=160720_brain_EPA_06_Neg; MgfId=1365

   

PC 34:1

1-(11Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine

C42H82NO8P (759.5777742)


Found in mouse brain; TwoDicalId=16; MgfFile=160720_brain_AA_19_Neg; MgfId=1172

   

PC 34:2

1-hexadecanoyl-2-(11Z,13Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C42H80NO8P (757.562125)


Found in mouse brain; TwoDicalId=253; MgfFile=160720_brain_DHA_14_Neg; MgfId=939 Found in mouse small intestine; TwoDicalId=9; MgfFile=160907_Small_Intestine_DHA_Neg_14; MgfId=1162

   

PC 34:3

1-(9Z-hexadecenoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C42H78NO8P (755.5464757999999)


Found in mouse heart; TwoDicalId=468; MgfFile=160902_Heart_Control_Neg_05; MgfId=576 Found in mouse liver; TwoDicalId=155; MgfFile=160824_Liver_normal_Neg_01; MgfId=481 Found in mouse muscle; TwoDicalId=150; MgfFile=160824_Muscle_normal_Neg_01_sute; MgfId=755

   

PC 36:4

1-(9Z,12Z,15Z-octadecatrienoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C44H80NO8P (781.562125)


Found in mouse small intestine; TwoDicalId=88; MgfFile=160907_Small_Intestine_EPA_Neg_08; MgfId=999 Found in mouse small intestine; TwoDicalId=10; MgfFile=160907_Small_Intestine_AA_Neg_16; MgfId=1103

   

PC 36:5

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C44H78NO8P (779.5464757999999)


Found in mouse liver; TwoDicalId=309; MgfFile=160824_Liver_EPA_Neg_10; MgfId=479 Found in mouse muscle; TwoDicalId=160; MgfFile=160824_Muscle_AA_Neg_19; MgfId=647 Found in mouse small intestine; TwoDicalId=14; MgfFile=160907_Small_Intestine_EPA_Neg_06; MgfId=985

   

PC 38:5

1-(8Z,11Z,14Z,17Z-eicosatetraenoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C46H82NO8P (807.5777742)


Found in mouse kidney; TwoDicalId=81; MgfFile=160827_Kidney_AA_Neg_16; MgfId=1232 Found in mouse small intestine; TwoDicalId=76; MgfFile=160907_Small_Intestine_EPA_Neg_06; MgfId=1236 Found in mouse heart; TwoDicalId=32; MgfFile=160902_Heart_EPA_Neg_09; MgfId=828 Found in mouse heart; TwoDicalId=58; MgfFile=160902_Heart_AA_Neg_17_never; MgfId=965 Found in mouse muscle; TwoDicalId=22; MgfFile=160824_Muscle_EPA_Neg_06; MgfId=805

   

PC 38:6

1-(8Z,11Z,14Z,17Z-eicosatetraenoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C46H80NO8P (805.562125)


Found in mouse kidney; TwoDicalId=138; MgfFile=160827_Kidney_EPA_Neg_08; MgfId=1036 Found in mouse heart; TwoDicalId=57; MgfFile=160902_Heart_AA_Neg_20; MgfId=732 Found in mouse heart; TwoDicalId=4; MgfFile=160902_Heart_DHA_Neg_12; MgfId=843

   

PC 40:0

1-tetracosanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine

C48H96NO8P (845.6873185999999)


Found in mouse brain; TwoDicalId=455; MgfFile=160720_brain_AA_18_Neg; MgfId=2364

   

PC 38:7

1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphocholine

C46H78NO8P (803.5464757999999)


Found in mouse kidney; TwoDicalId=207; MgfFile=160827_Kidney_AA_Neg_20; MgfId=931 Found in mouse muscle; TwoDicalId=77; MgfFile=160824_Muscle_DHA_Neg_12; MgfId=635

   

PC 39:6

1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C47H82NO8P (819.5777742)


Found in mouse heart; TwoDicalId=169; MgfFile=160902_Heart_DHA_Neg_12; MgfId=954

   

PC 36:1

1-(11Z-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phosphocholine

C44H86NO8P (787.6090726)


Found in mouse brain; TwoDicalId=66; MgfFile=160720_brain_EPA_08_Neg; MgfId=1487

   

PC 36:2

Choline phosphate, 3-ester with L-1,2-diolein;Olein, 1,2-di-, L-, dihydrogen phosphate, monoester with choline hydroxide

C44H84NO8P (785.5934234)


Found in mouse brain; TwoDicalId=185; MgfFile=160720_brain_DHA_12_Neg; MgfId=1172 Found in mouse small intestine; TwoDicalId=38; MgfFile=160907_Small_Intestine_EPA_Neg_08; MgfId=1404

   

PC 38:1

1-tetradecanoyl-2-(15Z-tetracosenoyl)-sn-glycero-3-phosphocholine

C46H90NO8P (815.640371)


Found in mouse brain; TwoDicalId=466; MgfFile=160720_brain_AA_19_Neg; MgfId=1990 Found in mouse heart; TwoDicalId=3434; MgfFile=160902_Heart_EPA_Neg_09; MgfId=1343

   

PC 38:2

1-heneicosanoyl-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C46H88NO8P (813.6247218)


Found in mouse brain; TwoDicalId=556; MgfFile=160720_brain_EPA_07_Neg; MgfId=1392 Found in mouse kidney; TwoDicalId=1547; MgfFile=160827_Kidney_DHA_Neg_14; MgfId=1798 Found in mouse lung; TwoDicalId=1203; MgfFile=160901_Lung_DHA_Neg_15; MgfId=1299

   

PC 40:5

1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C48H86NO8P (835.6090726)


Found in mouse spleen; TwoDicalId=273; MgfFile=160729_spleen_EPA_07_Neg_never; MgfId=1295 Found in mouse heart; TwoDicalId=67; MgfFile=160902_Heart_EPA_Neg_09; MgfId=1067

   

PC 40:6

1-(11Z-octadecenoyl)-2-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycero-3-phosphocholine

C48H84NO8P (833.5934234)


Found in mouse lung; TwoDicalId=700; MgfFile=160901_Lung_EPA_Neg_07_never; MgfId=938 Found in mouse heart; TwoDicalId=314; MgfFile=160902_Heart_EPA_Neg_09; MgfId=852 Found in mouse muscle; TwoDicalId=302; MgfFile=160824_Muscle_EPA_Neg_07_never; MgfId=878 Found in mouse heart; TwoDicalId=11; MgfFile=160902_Heart_DHA_Neg_12_never; MgfId=1112

   

PC 40:7

1-(9Z,12Z-octadecadienoyl)-2-(4Z,7Z,10Z,13Z,16Z-docosapentaenoyl)-sn-glycero-3-phosphocholine

C48H82NO8P (831.5777742)


Found in mouse muscle; TwoDicalId=187; MgfFile=160824_Muscle_normal_Neg_03; MgfId=628 Found in mouse heart; TwoDicalId=82; MgfFile=160902_Heart_DHA_Neg_12; MgfId=853

   

PC 40:8

1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphocholine

C48H80NO8P (829.562125)


Found in mouse muscle; TwoDicalId=49; MgfFile=160824_Muscle_DHA_Neg_12_never; MgfId=758 Found in mouse heart; TwoDicalId=24; MgfFile=160902_Heart_DHA_Neg_12_never; MgfId=808

   

PC 40:9

1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphocholine

C48H78NO8P (827.5464757999999)


Found in mouse muscle; TwoDicalId=293; MgfFile=160824_Muscle_DHA_Neg_12; MgfId=604

   

PC 42:7

1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphocholine

C50H86NO8P (859.6090726)


Found in mouse heart; TwoDicalId=440; MgfFile=160902_Heart_DHA_Neg_12; MgfId=1087

   

PC 42:10

1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycero-3-phosphocholine

C50H80NO8P (853.562125)


Found in mouse plasma; TwoDicalId=2330; MgfFile=160819_Plasma_EPA_Neg_10; MgfId=536

   

PC 42:11

1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine

C50H78NO8P (851.5464757999999)


Found in mouse muscle; TwoDicalId=227; MgfFile=160824_Muscle_EPA_Neg_07; MgfId=487

   

PC 44:12

1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine

C52H80NO8P (877.562125)


Found in mouse heart; TwoDicalId=147; MgfFile=160902_Heart_DHA_Neg_12; MgfId=701

   

PC 25:0

1-undecanoyl-2-tetradecanoyl-sn-glycero-3-phosphocholine

C33H66NO8P (635.4525806)


   

PC 31:1

1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphocholine

C39H76NO8P (717.5308266)


   

PC 43:6

1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine

C51H90NO8P (875.640371)


   

PC 36:0

1-pentadecanoyl-2-heneicosanoyl-sn-glycero-3-phosphocholine

C44H88NO8P (789.6247218)


   

PC 20:0

1-O-Octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine

C28H56NO8P (565.3743346)


   

PC 26:0

1-tetradecanoyl-2-dodecanoyl-sn-glycero-3-phosphocholine

C34H68NO8P (649.4682298)


   

PC 28:1

1-(9Z-tetradecenoyl)-2-tetradecanoyl-glycero-3-phosphocholine

C36H70NO8P (675.483879)


   

PC 28:2

1-decanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C36H68NO8P (673.4682298)


   

PC 29:0

1-tetradecanoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C37H74NO8P (691.5151774)


   

PC 35:0

1-heneicosanoyl-2-tetradecanoyl-sn-glycero-3-phosphocholine

C43H86NO8P (775.6090726)


   

PC 14:0

1-octanoyl-2-hexanoyl-sn-glycero-3-phosphocholine

C22H44NO8P (481.28043940000003)


   

PC 22:0

1-hexadecanoyl-2-hexanoyl-sn-glycero-3-phosphocholine

C30H60NO8P (593.405633)


   

PC 24:0

1,2-didodecanoyl-sn-phosphatidylcholine;1,2-Didodecanoyl-sn-glycero-3-phosphocholine;1,2-Dilauroyl-L-phosphatidylcholine

C32H64NO8P (621.4369314)


   

PC 34:6

1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphocholine

C42H72NO8P (749.4995282)


   

PC 38:0

1-tetradecanoyl-2-tetracosanoyl-sn-glycero-3-phosphocholine

C46H92NO8P (817.6560202)


   

PC 32:4

1-tetradecanoyl-2-(9E,11E,13E,15E-octadecatetraenoyl)-sn-glycero-3-phosphocholine

C40H72NO8P (725.4995282)


   

PC 16:0

1-tetradecanoyl-2-acetyl-sn-glycero-3-phosphocholine

C24H48NO8P (509.3117378)


   

PC 18:0

1-O-Palmitoyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine

C26H52NO8P (537.3430362)


   

PC 39:5

1-heptadecanoyl-2-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycero-3-phosphocholine

C47H84NO8P (821.5934234)


   

PC 42:0

1-tetracosanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine

C50H100NO8P (873.718617)


   

PC 19:0

1-hexadecanoyl-2-propionyl-sn-glycero-3-phosphocholine

C27H54NO8P (551.3586854)


   

PC 19:1

1-hexadecanoyl-2-(2E-propionyl)-sn-glycero-3-phosphocholine

C27H52NO8P (549.3430362)


   

PC 21:0

1-octadecanoyl-2-propionyl-sn-glycero-3-phosphocholine

C29H58NO8P (579.3899838)


   

PC 21:1

1-octadecanoyl-2-(2E-propionyl)-sn-glycero-3-phosphocholine

C29H56NO8P (577.3743346)


   

PC 18:1

1-(9Z-hexadecenoyl)-2-acetyl-sn-glycero-3-phosphocholine

C26H50NO8P (535.327387)


   

PC 27:0

1-undecanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine

C35H70NO8P (663.483879)


   

PC 29:1

1-(9Z-pentadecenoyl)-2-tetradecanoyl-glycero-3-phosphocholine

C37H72NO8P (689.4995282)


   

PC 40:3

1-(13Z,16Z-docosadienoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C48H90NO8P (839.640371)


   

PC 42:1

1-(15Z-tetracosenoyl)-2-octadecanoyl-sn-glycero-3-phosphocholine

C50H98NO8P (871.7029678)


   

PC 44:0

1-nonadecanoyl-2-pentacosanoyl-sn-glycero-3-phosphocholine

C52H104NO8P (901.7499154)


   

PC 20:1

1-acetyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine

C28H54NO8P (563.3586854)


   

PC 22:1

1-butyryl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine

C30H58NO8P (591.3899838)


   

PC 36:8

1,2-di-(9Z,11E,13E,15Z-octadecatetraenoyl)-sn-glycero-3-phosphocholine

C44H72NO8P (773.4995282)


   

PC 37:0

1-nonadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine

C45H90NO8P (803.640371)


   

PC 4:0

1,2-diacetyl-sn-glycero-3-phosphocholine

C12H24NO8P (341.1239474)


   

PC 40:2

1-(15Z-tetracosenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phosphocholine

C48H92NO8P (841.6560202)


   

PC 42:5

1-(13Z,16Z-docosadienoyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphocholine

C50H90NO8P (863.640371)


   

PC 42:6

1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-(11Z,14Z-eicosadienoyl)-glycero-3-phosphocholine

C50H88NO8P (861.6247218)


   

PC 44:1

1-tetracosanoyl-2-(11Z-eicosenoyl)-sn-glycero-3-phosphocholine

C52H102NO8P (899.7342662)


   

PC 46:0

1-eicosanoyl-2-hexacosanoyl-sn-glycero-3-phosphocholine

C54H108NO8P (929.7812137999999)


   

PC 52:4

1-dotriacontanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine

C60H112NO8P (1005.8125122)


   

PC 39:0

1-heneicosanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine

C47H94NO8P (831.6716693999999)


   

PC 46:1

1-docosanoyl-2-(15Z-tetracosenoyl)-sn-glycero-3-phosphocholine

C54H106NO8P (927.7655646)


   

PC 48:0

1-docosanoyl-2-hexacosanoyl-sn-glycero-3-phosphocholine

C56H112NO8P (957.8125122)


   

PC 44:2

1-(13Z,16Z-docosadienoyl)-2-docosanoyl-glycero-3-phosphocholine

C52H100NO8P (897.718617)


   

PC 41:0

1-tricosanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine

C49H98NO8P (859.7029678)


   

PC 46:2

1,2-di-(9Z-tricosenoyl)-sn-glycero-3-phosphocholine

C54H104NO8P (925.7499154)


   

PC 48:2

1,2-di-(15Z-tetracosenoyl)-sn-glycero-3-phosphocholine

C56H108NO8P (953.7812137999999)


   

PC 43:0

1-pentacosanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine

C51H102NO8P (887.7342662)


   

PC 6:0

1,2-dipropionyl-sn-glycero-3-phosphocholine

C14H28NO8P (369.15524580000005)


   

PC 50:0

1-tetratriacontanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine

C58H116NO8P (985.8438106)


   

PC 52:0

1-hexatriacontanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine

C60H120NO8P (1013.875109)


   

PC 8:0

1,2-dibutyryl-sn-glycero-3-phosphocholine

C16H32NO8P (397.1865442)


   

PC 10:0

1,2-divaleryl-sn-glycero-3-phosphocholine

C18H36NO8P (425.21784260000004)


   

PC 12:0

1,2-Dihexanoyl-L-alpha-glycerophosphorylcholine

C20H40NO8P (453.24914100000007)


   

PC 12:4

1,2-di-(2E,4E-hexadienoyl)-sn-glycero-3-phosphocholine

C20H32NO8P (445.1865442)


   

PC 20:4

1-(3E,5E-hexadienoyl)-2-(11E,13E-tetradecadienoyl)-sn-glycero-3-phosphocholine

C28H48NO8P (557.3117378)


   

PC 16:4

1,2-di-(2E,4E-octadienoyl)-sn-glycero-3-phosphocholine

C24H40NO8P (501.24914100000007)


   

PC 26:1

1-decanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phosphocholine

C34H66NO8P (647.4525806)


   

PC 27:1

1-(9Z-tetradecenoyl)-2-tridecanoyl-glycero-3-phosphocholine

C35H68NO8P (661.4682298)


   

PC 29:2

1-(9Z-pentadecenoyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphocholine

C37H70NO8P (687.483879)


   

PC 30:2

1-(9Z,12Z-heptadecadienoyl)-2-tridecanoyl-glycero-3-phosphocholine

C38H72NO8P (701.4995282)


   

PC 30:3

1-(9Z,12Z,15Z-octadecatrienoyl)-2-dodecanoyl-glycero-3-phosphocholine

C38H70NO8P (699.483879)


   

PC 30:4

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-dodecanoyl-glycero-3-phosphocholine

C38H68NO8P (697.4682298)


   

PC 32:5

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphocholine

C40H70NO8P (723.483879)


   

PC 31:2

1-(9Z,12Z-heptadecadienoyl)-2-tetradecanoyl-glycero-3-phosphocholine

C39H74NO8P (715.5151774)


   

PC 31:3

1-(9Z,12Z-heptadecadienoyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphocholine

C39H72NO8P (713.4995282)


   

PC 31:4

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-tridecanoyl-glycero-3-phosphocholine

C39H70NO8P (711.483879)


   

PC 33:3

1-(9Z,12Z,15Z-octadecatrienoyl)-2-pentadecanoyl-glycero-3-phosphocholine

C41H76NO8P (741.5308266)


   

PC 33:4

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-pentadecanoyl-glycero-3-phosphocholine

C41H74NO8P (739.5151774)


   

PC 33:5

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphocholine

C41H72NO8P (737.4995282)


   

PC 35:6

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C43H74NO8P (763.5151774)


   

PC 36:7

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphocholine

C44H74NO8P (775.5151774)


   

PC 37:1

1-heneicosanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphocholine

C45H88NO8P (801.6247218)


   

PC 37:2

1-(13Z,16Z-docosadienoyl)-2-pentadecanoyl-glycero-3-phosphocholine

C45H86NO8P (799.6090726)


   

PC 37:3

1-(13Z,16Z-docosadienoyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphocholine

C45H84NO8P (797.5934234)


   

PC 37:5

1-(8Z,11Z,14Z-eicosatrienoyl)-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C45H80NO8P (793.562125)


   

PC 37:7

1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C45H76NO8P (789.5308266)


   

PC 39:1

1-heneicosanoyl-2-(9Z-octadecenoyl)-glycero-3-phosphocholine

C47H92NO8P (829.6560202)


   

PC 39:2

1-heneicosanoyl-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphocholine

C47H90NO8P (827.640371)


   

PC 39:3

1-heneicosanoyl-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphocholine

C47H88NO8P (825.6247218)


   

PC 39:7

1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-2-(9Z-heptadecenoyl)-glycero-3-phosphocholine

C47H80NO8P (817.562125)


   

PC 39:8

1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphocholine

C47H78NO8P (815.5464757999999)


   

PC 38:9

1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphocholine

C46H74NO8P (799.5151774)


   

PC 40:10

1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-2-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphocholine

C48H76NO8P (825.5308266)


   

PC 41:1

1-heneicosanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphocholine

C49H96NO8P (857.6873185999999)


   

PC 41:2

1-heneicosanoyl-2-(11Z,14Z-eicosadienoyl)-glycero-3-phosphocholine

C49H94NO8P (855.6716693999999)


   

PC 41:4

1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-nonadecanoyl-glycero-3-phosphocholine

C49H90NO8P (851.640371)


   

PC 41:6

1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-2-nonadecanoyl-glycero-3-phosphocholine

C49H86NO8P (847.6090726)


   

PC 41:3

1-(13Z,16Z-docosadienoyl)-2-(9Z-nonadecenoyl)-glycero-3-phosphocholine

C49H92NO8P (853.6560202)


   

PC 41:5

1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-(9Z-nonadecenoyl)-glycero-3-phosphocholine

C49H88NO8P (849.6247218)


   

PC 41:7

1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-2-(9Z-nonadecenoyl)-glycero-3-phosphocholine

C49H84NO8P (845.5934234)


   

PC 42:4

1-(15Z-tetracosenoyl)-2-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphocholine

C50H92NO8P (865.6560202)


   

PC 42:3

1-(13Z,16Z-docosadienoyl)-2-(11Z-eicosenoyl)-glycero-3-phosphocholine

C50H94NO8P (867.6716693999999)


   

PC 42:8

1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycero-3-phosphocholine

C50H84NO8P (857.5934234)


   

PC 42:9

1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphocholine

C50H82NO8P (855.5777742)


   

PC 43:1

1-(11Z-docosenoyl)-2-heneicosanoyl-glycero-3-phosphocholine

C51H100NO8P (885.718617)


   

PC 43:2

1-(13Z,16Z-docosadienoyl)-2-heneicosanoyl-glycero-3-phosphocholine

C51H98NO8P (883.7029678)


   

PC 43:4

1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-heneicosanoyl-glycero-3-phosphocholine

C51H94NO8P (879.6716693999999)


   

PC 44:4

1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-docosanoyl-glycero-3-phosphocholine

C52H96NO8P (893.6873185999999)


   

PC 44:6

1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-(13Z,16Z-docosadienoyl)-glycero-3-phosphocholine

C52H92NO8P (889.6560202)


   

PC 44:3

1-(13Z,16Z-docosadienoyl)-2-(11Z-docosenoyl)-glycero-3-phosphocholine

C52H98NO8P (895.7029678)


   

PC 44:5

1-(7Z,10Z,13Z,16Z-docosatetraenoyl)-2-(11Z-docosenoyl)-glycero-3-phosphocholine

C52H94NO8P (891.6716693999999)


   

PC 44:7

1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-2-(11Z-docosenoyl)-glycero-3-phosphocholine

C52H90NO8P (887.640371)


   

PC 44:10

1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-glycero-3-phosphocholine

C52H84NO8P (881.5934234)


   

PC 54:12

1-(14Z,17Z,20Z,23Z,26Z,29Z-dotriacontahexaenoyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-glycero-3-phosphocholine

C62H100NO8P (1017.718617)


   

PC 56:12

1-(16Z,19Z,22Z,24Z,28Z,31Z-tetratriacontahexaenoyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z- docosahexaenoyl)-glycero-3-phosphocholine

C64H104NO8P (1045.7499154)


   

PC 56:9

1-(18Z,21Z,24Z,27Z,30Z-hexatriacontapentaenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycero-3-phosphocholine

C64H110NO8P (1051.796863)


   

PC 56:8

1-(21Z,24Z,27Z,30Z-hexatriacontatetraenoyl)-2-(5Z,8Z,11Z,14Z- eicosatetraenoyl)-glycero-3-phosphocholine

C64H112NO8P (1053.8125122000001)